Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The EBITDA margin is -403.32%.
Reported quarterly EBITDA margin; no daily interpolation.
Limited quarterly history available
EBITDA Margin needs at least three reported quarters before a meaningful chart is shown.
EBITDA MARGIN
-403.32%
EBITDA MARGIN AVG TTM
N/A
EBITDA MARGIN AVG 3Y
N/A
EBITDA MARGIN AVG 5Y
N/A
EBITDA MARGIN AVG 10Y
N/A
EBITDA MARGIN AVG 15Y
N/A
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Kyverna Therapeutics, Inc.
Market Cap
$376.93M
EBITDA Margin
-403.32%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$377.66M
EBITDA Margin
-107.01%
TTM Avg
-86.79%
3Y Avg
-53.66%
5Y Avg
-431.14%
Market Cap
$381.75M
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$370.48M
EBITDA Margin
-12.87%
TTM Avg
-20.20%
3Y Avg
-216.20%
5Y Avg
-209.97%
Market Cap
$383.60M
EBITDA Margin
-2.13%
TTM Avg
-2.60%
3Y Avg
-2.91%
5Y Avg
0.10%
Market Cap
$355.99M
EBITDA Margin
-153.75%
TTM Avg
-1289.79%
3Y Avg
-1338.35%
5Y Avg
-1135.96%
Market Cap
$354.37M
EBITDA Margin
-1371.56%
TTM Avg
-1336.69%
3Y Avg
-1827.03%
5Y Avg
-11314.18%
Market Cap
$353.28M
EBITDA Margin
-13.98%
TTM Avg
-3.54%
3Y Avg
-384.69%
5Y Avg
-2364.58%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Kyverna Therapeutics, Inc. (KYTX) | $376.93M | -403.32% | N/A | N/A | N/A |
| Arcturus Therapeutics Holdings Inc. (ARCT)vs › | $377.66M | -107.01% | -86.79% | -53.66% | -431.14% |
| MapLight Therapeutics, Inc. (MPLT)vs › | $381.75M | N/A | N/A | N/A | N/A |
| Canopy Growth Corporation (CGC)vs › | $370.48M | -12.87% | -20.20% | -216.20% | -209.97% |
| Orthofix Medical Inc. (OFIX)vs › | $383.60M | -2.13% | -2.60% | -2.91% | 0.10% |
| Orchestra BioMed Holdings, Inc. (OBIO)vs › | $355.99M | -153.75% | -1289.79% | -1338.35% | -1135.96% |
| Ocugen, Inc. (OCGN)vs › | $354.37M | -1371.56% | -1336.69% | -1827.03% | -11314.18% |
| Embecta Corp. (EMBC)vs › | $355.08M | 35.21% | 27.25% | 28.55% | 34.67% |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $353.28M | -13.98% | -3.54% | -384.69% | -2364.58% |
| Myriad Genetics, Inc. (MYGN)vs › | $402.82M | -1.71% | -2.46% | -6.59% | -11.17% |
Gross Margin
0.0%
EBITDA Margin
-403.3%
Operating Margin
0.0%
Net Margin
0.0%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2022-12-31 | -2979.08% |
